Education
About Us
Working with TipRanks
Follow Us
Cardiff Oncology, Inc. (DE:XE7C)
:XE7C
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 683.00K | $ 488.00K | $ 386.00K | $ 359.00K | $ 365.99K |
| Gross Profit | $ 683.00K | $ 488.00K | $ 186.00K | $ -141.00K | $ -10.87M |
| Operating Income | $ -48.65M | $ -45.41M | $ -39.90M | $ -28.86M | $ -19.09M |
| EBITDA | $ -48.65M | $ -45.01M | $ -39.67M | $ -28.40M | $ -18.84M |
| Net Income | $ -45.45M | $ -41.44M | $ -37.51M | $ -27.74M | $ -19.28M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 91.75M | $ 74.82M | $ 105.27M | $ 140.82M | $ 130.98M |
| Total Assets | $ 97.19M | $ 81.64M | $ 116.19M | $ 149.54M | $ 134.73M |
| Total Debt | $ 1.52M | $ 2.15M | $ 2.71M | $ 3.12M | $ 869.50K |
| Net Debt | $ -49.95M | $ -19.51M | $ -13.63M | $ -8.82M | $ -130.11M |
| Total Liabilities | $ 14.24M | $ 11.90M | $ 9.85M | $ 9.13M | $ 6.57M |
| Stockholders' Equity | $ 82.95M | $ 69.74M | $ 106.34M | $ 140.42M | $ 128.16M |
| Cash Flow | |||||
| Free Cash Flow | $ -37.77M | $ -31.47M | $ -34.71M | $ -23.25M | $ -16.53M |
| Operating Cash Flow | $ -37.69M | $ -30.89M | $ -33.82M | $ -23.04M | $ -16.31M |
| Investing Cash Flow | $ 13.73M | $ 36.20M | $ 38.15M | $ -131.45M | $ -211.88K |
| Financing Cash Flow | $ 53.78M | $ 0.00 | $ 75.00K | $ 35.45M | $ 137.31M |